Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies.
Location: United States
Investors 1
| Date | Name | Website |
| - | MRL Ventur... | mrlv.com |
Mentions in press and media 3
| Date | Title | Description |
| 25.03.2021 | Viridian Therapeutics closes 2020 with $127.6M in cash | Viridian Therapeutics Inc. (Nasdaq: VRDN) said it has the cash to keep it afloat through late 2023 after consummating a major merger earlier this year. The Boulder company reported having $127.6 million in cash and equivalents on hand at th... |
| 08.08.2019 | 26 jobs lost at Boulder’s MiRagen as part of corporate restructuring | Boulder-based biopharmaceutical company, miRagen Therapeutics Inc. is laying off about 26 employees to reduce costs, the company recently announced. It will help the company to focus on the clinical development of cobomarsen, being develope... |
| 26.04.2019 | Boulder-based miRagen announces promising clinical trial data | Boulder-based biopharmaceutical company, miRagen Therapeutics Inc. announced Friday new clinical data for cobomarsen in adult T-cell leukemia/lymphoma patients at the 19th Annual HTLV Congress in Lima, Peru, according to a news release. The... |